Search Results
Showing Results for diagnosis
In this expert Q&A, Dr Ferenc Kuhn, an ocular trauma specialist (having designed the BETT and the OTS systems) and Chairman of the International Society of Ocular Trauma, shares his insights into the assessment and management of traumatic cataracts and the principles that guide his surgical decision-making.
Dr Syed Shoeb Ahmad is a leading glaucoma specialist and practising ophthalmologist based in India. A well-published expert in the field, he is also the creator of 'Glaucoma Specialist Blog: The Glog', an online resource designed to support ophthalmologists at all levels. In this Q&A, he shares his insights on the challenges of early diagnosis, advances in treatment, and the often-overlooked connection between glaucoma and systemic disease.
We are delighted to share the latest issue of touchREVIEWS in Ophthalmology, showcasing a diverse range of articles that highlight the innovation, interdisciplinary collaboration and continued advances driving progress in eye care today. We begin this issue with an important ...
Breast carcinoma is the most common cancer in females. An estimated 2.3 million new cases of breast carcinoma are diagnosed annually worldwide.1Â These patients have potential risks of ocular complications not only from the secondaries in the eye but also due ...
During the WCC IX congress, Prof. Elisabeth Cohen, Department of Ophthalmology at NYU Grossman School of Medicine, delivered a presentation on the Management of Zoster Keratitis. In the following Q&A, she shares her clinical insights on diagnosis, treatment strategies, and prevention of this complex and often under-recognized condition.
Join us as Dr Roizenblatt discusses the motivations that shaped her career, her early contributions to making a meaningful impact, and her vision for the future of her groundbreaking research in retinal surgery.
Glaucoma is life-changing. During Glaucoma Awareness Month this January, the Glaucoma Foundation (TGF) is bringing a spotlight to patients and others who are tackling this disease. How are they struggling? How are they thriving?Â
As we eagerly await the innovations and breakthroughs that 2025 promises ophthalmlology, we reached out to some of our esteemed editorial board members to share their insights.
We have seen plenty of innovation in ophthalmology, with researchers and clinicians making significant strides in how eye conditions are treated and managed. From improving drug delivery methods to harnessing the potential of gene and stem cell therapies, 2024 has been a year of promising progress across multiple areas. As we edge closer to 2025, we are eager to see what advancements will further improve vision and eye care. To envision what lies ahead, we turn to our expert editorial board to share their insights on the developments shaping the future of ophthalmology:
The World Glaucoma Association (WGA) is thrilled to announce the 11th World Glaucoma Congress, scheduled for June 25-28, 2025, in Honolulu, Hawaii, USA. Held biennially, the WGC is the largest international meeting dedicated to glaucoma, providing a platform for young researchers to present their work and gain recognition within the global glaucoma community.
The uvea is a vascular stratum that includes the iris, ciliary body and choroid. Uveitis is defined as inflammation of a part of the uvea or its entirety, but it is also used to describe inflammatory processes of any part ...
Age-related macular degeneration (AMD) is a chronic deterioration and dysfunction of the outer retinal tissue and Bruch’s membrane (BrM). It is the leading cause of vision loss in people older than 60 years and is estimated to affect 288 million people ...
Dry eye disease (DED) is a prevalent ocular condition characterized by discomfort, visual disturbances and tear film instability due to insufficient tear production or rapid tear evaporation.1Â With an increasing global incidence (i.e. up to 50%) and its significant impact ...
Thyroid eye disease (TED) is an autoimmune condition that can lead to significant visual impairment, facial disfigurement and decreased quality of life. It affects 16 out of every 100,000 females and 2.9 out of every 100,000 males. Risk factors for TED include age, female ...
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
